PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced …
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies …
Rehabilitation Hospital of Columbus, a 40-bed inpatient rehabilitation hospital, now open in Georgia
Piedmont and Encompass Health (NYSE: EHC) announce the opening of the Rehabilitation Hospital of Columbus, …
Apollo Hospitals, Navi Mumbai launches Advanced Rehabilitation services with advanced technologies
Apollo Hospitals, Navi Mumbai (AHNM), the leading super-speciality quaternary care hospital, today announced the launch …
Kamineni Hospital Elevates Neurological Care with the Launch of State-of-the-Art Advanced Neuro Center
In a remarkable stride for neurological healthcare, Kamineni Hospital launches the Kamineni Advanced Neuro Center. …
Hansa Biopharma Concludes Enrollment for Innovative Imlifidase Phase 2 Trial Targeting Guillain-Barré Syndrome
Hansa Biopharma (Nasdaq Stockholm: HNSA), a vanguard in the field of enzyme technology for the …
